本页面由Tiger Trade Technology Pte. Ltd.提供服务

神经分泌生物科学

141.37
-1.0700-0.75%
盘后:141.370.00000.00%19:33 EDT
成交量:109.21万
成交额:1.55亿
市值:144.20亿
市盈率:20.72
高:143.63
开:142.37
低:140.89
收:142.44
52周最高:186.12
52周最低:122.14
股本:1.02亿
流通股本:9,999.56万
量比:0.83
换手率:1.09%
股息:- -
股息率:- -
每股收益(TTM):6.82
每股收益(LYR):4.67
净资产收益率:22.09%
总资产收益率:11.70%
市净率:3.90
市盈率(LYR):30.27

数据加载中...

2026/09/29

重要事件披露

Form 8-K - Current report
2026/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/31

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/07/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/31

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/07/30

重要事件披露

Form 8-K - Current report
2026/07/27

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/28

重要事件披露

Form 8-K - Current report
2026/05/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities